🧬

Incorrect password. Please try again.

⚠️ DISCLAIMER: Rothschild Corp is a Hong Kong-registered private enterprise, independent from the historical European-banking Rothschild dynasty. All partnership listings are for informational purposes. Formal cooperation requires legal contracts and regulatory approvals.
DOW 42,567.89 ▲ 0.82% ◆ S&P 500 5,789.45 ▲ 1.21% ◆ NASDAQ 18,234.67 ▼ 0.34% ◆ HANG SENG 19,456.78 ▲ 1.56% ◆ SSE 3,245.89 ▲ 0.67% ◆ DAX 18,876.34 ▲ 0.45% ◆ USD/CNY 7.2345 ▼ 0.12% ◆ GOLD $2,456.70 ▲ 0.34% ◆ OIL (WTI) $78.45 ▼ 0.89% ◆ H₂ SPOT $4.89 ▲ 2.34% ◆ BTC $67,234 ▲ 1.12% ◆ EURO $1.0874 ▼ 0.08% ◆ SILVER $29.45 ▲ 0.56% ◆ NAT GAS $2.87 ▼ 1.23% ◆
HomeResearchCCPFLPartnersGlobal FootprintContact
23Research Programs
16Export Nations
47+Global Partners
19Years of Legacy
⚜️CCPFL · Since 2007
🧬 Peptide Therapeutics · APIs · CDMO🏛️ 333 Anren Ancient Town📧 [email protected]

🧬 Rothschild Biotech

Advancing Life Sciences
through Innovation

Pioneering Peptide Therapeutics · APIs · Biologics · CDMO services for global pharmaceutical partners.

📍 333 Anren Ancient Town · Dayi County · Chengdu · Sichuan · PRC

🧪Peptide R&DTherapeutic PeptidesLIVE💊API DevelopmentActive IngredientsLIVE🧬BiologicsBiological TherapeuticsLIVE🏭CDMO ServicesContract ManufacturingLIVE🤝Global Partners47+ Enterprises · 5 Continents47+📞ContactWeChat: RothschildMCONNECT
📊 Biotech MetricsUpdated: just now
$1.8BAnnual Revenue▲ 18.4%
23Research Programs▲ 5 new
34Active Patents▲ 15%
16Export Countries▲ 3 new
📈 Projected Growth: +22.4% YoY🏆 Industry Ranking: #12
📈 Research Pipeline2026 · Q3
93%
Peptides
78%
APIs
85%
Biologics
68%
CDMO
55%
R&D
72%
Clinical
Target: 100%Current Average: 75.2%

🧬 Research Divisions

Artemis Bridge™ Ecosystem
🔬 Active🧪Peptide TherapeuticsNovel peptide drugs · Targeted therapies · Oncology🔬 12 active programs
🔬 Active💊API DevelopmentActive Pharmaceutical Ingredients · Generic APIs⚗️ 8 active programs
🔬 Active🧬Biologics ResearchMonoclonal antibodies · Cell therapies · Vaccines🧫 5 active programs
🔬 Active🏭CDMO ServicesContract manufacturing · Scale-up · Commercial⚙️ 3 active programs
⚜️ The CCPFL Doctrine
"The crest is not a symbol of privilege. It is a symbol of duty." — Dr. Michael Rothschild MD
CClassDignity · Refinement · Education
CCultureHeritage · Tradition · Global Perspective
PPolite SocietyDialogue · Respect · Civility
FFamilyGenerations · Stewardship · Legacy
LLegacyArchive · Future · Eternal Impact
The permanent governance framework for multi-generational industrial stewardship · Since 2007

🤝 Global Partner Network

47+ enterprises · 16 nations · 5 continents
🇨🇳China
🇺🇸USA
🇩🇪Germany
🇬🇧UK
🇫🇷France
🇯🇵Japan
🇰🇷Korea
🇦🇺Australia
🇨🇦Canada
🇮🇳India
🇧🇷Brazil
🇿🇦S. Africa
🇸🇦Saudi
🇸🇬Singapore
🇦🇪UAE
🇲🇽Mexico
🇮🇹Italy
🇪🇸Spain
🇳🇱Netherlands
🇨🇭Switzerland
🌍 The Artemis Bridge™ — Global Footprint
Connecting Chengdu to 12 strategic cities across 5 continents
Global Headquarters Regional Office
ChengduGlobal HQ
BeijingGov't Affairs
ShanghaiFinance Hub
Hong KongLegal Hub
TokyoJapan Hub
SeoulKorea Hub
SingaporeSE Asia Hub
DubaiMiddle East Hub
LondonEurope Hub
NYCAmericas Hub
SydneyPacific Hub
ParisEU Hub
BerlinGermany Hub
13Global Offices
5Continents
16Export Nations
47+Partners

📞 Get in Touch

How can we help you? How can we work together? How can we build a legacy together?

Email

[email protected]

Corp Email

[email protected]

WeChat

RothschildM

Headquarters

333 Anren Ancient Town · Dayi County · Chengdu · Sichuan 611330 · PRC

⚜️

Rothschild Corp Limited

Hong Kong SAR · Registered

Est. 2007 · CCPFL Since Inception

Global Headquarters
🇨🇳
Listed